Claraphi Advisory Network’s Amgen AMGN Stock Holding History

Claraphi Advisory Network’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,484	Closed	-$604K	–	196
2022 Q2	$604K	Buy	+2,484	New	+$609K	0.21%	110
2020 Q2	–	Sell	-560	Closed	-$114K	–	321
2020 Q1	$114K	Buy	+560	New	+$122K	0.05%	299
2019 Q3	–	Sell	-1,161	Closed	-$214K	–	401
2019 Q2	$214K	Buy	+1,161	New	+$208K	0.13%	202

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Claraphi Advisory Network's AMGN Position: Q3 2022 in Review

Claraphi Advisory Network sold out of Amgen (AMGN) in Q3 2022, closing a stake of 2,484 shares — an estimated $604K sold.

Claraphi Advisory Network first reported a position in AMGN in Q2 2019 and held it in 3 quarters. The position peaked at $604K in Q2 2022. 2,323 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

Claraphi Advisory Network reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
Claraphi Advisory Network sold 2,484 Amgen shares in Q3 2022, an estimated $604K.
Claraphi Advisory Network first reported a position in Amgen in Q2 2019 and held it in 3 quarters.
Claraphi Advisory Network's Amgen position peaked at $604K in Q2 2022.
2,323 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Claraphi Advisory Network's 13F filing for Q3 2022, filed 15 Nov 2022.